Track the AlzeCure Pharma AB share price and the full insider trade history of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, AlzeCure Pharma AB has recorded 10 insider filings. Market capitalisation: €798.2m. The latest transaction was disclosed on 4 July 2026 (Purchase). Among the most active insiders: Martin Jönsson. Every trade is accessible without an account.
10
Insider Decl.
n/a
Thresholds
€303,442
10 ops.
Buy Volume
n/a
n/a
Sell Volume
47Σ signal
Buys €303,442n/a Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
20,000 shares@ SEK 8.97100.0% of flowAktieISINISIN SE0010133785FI:A001P627-1
10 of 10 declarations
Acerca de AlzeCure Pharma AB
AlzeCure Pharma AB es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para enfermedades neurodegenerativas, particularmente la enfermedad de Alzheimer. Cotiza en el mercado XSTO.